Darren Cline is a seasoned pharmaceutical industry leader with more than 30 years of strategic and operational experience and a track record of delivering results – most notably in his work launching and commercializing therapies.
Most recently, he served as President and Chief Executive Officer of Epygenix Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for rare epilepsies. Before joining Epygenix, Darren served as the U.S. Chief Commercial Officer of GW Pharmaceuticals prior to the Company’s acquisition by Jazz Pharmaceuticals. Darren also held the role of Executive Vice President, Commercial at Seagen Inc. and before that held key commercial leadership roles at Intermune Inc., Alexion Pharmaceuticals, Inc. and Amgen Inc.
Darren currently serves on the Board of Directors of Pliant Therapeutics, Inc. and Pyxis Oncology, Inc. He previously served on the Board of Stemline Therapeutics prior to the Company’s acquisition by Menarini Group.
He received his B.S. in Business Marketing from San Diego State University and an M.B.A. from Pepperdine University.